Alteration of Skin Sympathetic Nerve Activity after Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation
- PMID: 36013235
- PMCID: PMC9409853
- DOI: 10.3390/jpm12081286
Alteration of Skin Sympathetic Nerve Activity after Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation
Abstract
Autonomic system plays a pivotal role in the pathogenesis of paroxysmal atrial fibrillation (AF). Skin sympathetic nerve activity (SKNA) is a noninvasive tool for assessing sympathetic tone. However, data on changes in SKNA after ablation are limited. Here, we retrospectively enrolled 37 patients with symptomatic drug-refractory paroxysmal AF who underwent pulmonary vein isolation (PVI) with radiofrequency ablation (RFA) or cryoablation (CBA). SKNA was measured from the chest and right arm 1 day prior to ablation, as well as 1 day and 3 months after ablation. One day after ablation, the SKNA-Arm increased from 517.1 µV (first and third quartiles, 396.0 and 728.0, respectively) to 1226.2 µV (first and third quartiles, 555.2 and 2281.0), with an increase of 179.8% (125% and 376.0%) (p < 0.001); the SKNA-Chest increased from 538.2 µV (first and third quartiles, 432.9 and 663.9) to 640.0 µV (first and third quartiles, 474.2 and 925.6), with an increase of 108.3% (95.6% and 167.9%) (p = 0.004), respectively. In those without recurrence, there was a significant increase in SKNA 1 day after ablation as compared with those before ablation. Twelve patients received SKNA measurement 3 months after ablation; both SKNA-Arm (p = 0.31) and SKNA-Chest (p = 0.27) were similar to those before ablation, respectively. Among patients with symptomatic drug-refractory paroxysmal AF receiving PVI, increased SKNA was observed 1 day after ablation and returned to the baseline 3 months after ablation. Elevation of SKNA was associated with lower early and late recurrences following ablation.
Keywords: atrial fibrillation; autonomic system; pulmonary vein isolation; skin sympathetic nerve activity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- January C.T., Wann L.S., Alpert J.S., Calkins H., Cigarroa J.E., Cleveland J.C., Jr., Conti J.B., Ellinor P.T., Ezekowitz M.D., Field M.E., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2014;64:e1–e76. doi: 10.1016/j.jacc.2014.03.022. - DOI - PubMed
Grants and funding
- VGHUST107-G1-8-1/Taipei Veterans General Hospital
- V108C-073/Taipei Veterans General Hospital
- V108-031/Taipei Veterans General Hospital
- V109C-001/Taipei Veterans General Hospital
- V109C-005/Taipei Veterans General Hospital
- V110C-024/Taipei Veterans General Hospital
- V110-014/Taipei Veterans General Hospital
- VGHUST111-G1-8-1/Taipei Veterans General Hospital
- V111C-065/Taipei Veterans General Hospital
- MOST108-2314-B-010-051-MY3/Ministry of Science and Technology, Taiwan
- MOST108-2811-B-010-542/Ministry of Science and Technology, Taiwan
- MOST109-811-B-010-529/Ministry of Science and Technology, Taiwan
- MOST109-2314-B-075A-011-MY3/Ministry of Science and Technology, Taiwan
- MOST 110-2314-B-075A-014 -MY3/Ministry of Science and Technology, Taiwan
LinkOut - more resources
Full Text Sources
